Product Images Imatinib Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Imatinib Mesylate NDC 59651-241 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text describes a figure (Figure 1) showing the Progression-Free Survival of patients with Imatinib Mesylate arm and IFN+Ara-C arm. The number of patients with progression, censored at discontinuation, and censored at last follow-up are also shown. The Hazard Ratio and Log-rank Test statistic are also provided. The x-axis shows the number of months since randomization.*
This is a figure that shows the time taken for patients to progress to AP or BC using the ITT principle. The data is presented in a graph with the number of patients who progressed and were censored at discontinuation or last follow-up, respectively. The hazard ratio and p-value are also provided. The graph shows that the Imatinib Mesylate arm had a lower risk of progression compared to the IFN+Ara-C arm. The x-axis represents the time in months since randomization, while the y-axis represents the percentage of patients.*
The text describes Figure 5 which shows the overall survival for a study 2 with ITT population. The X-axis shows the time in months and the Y-axis shows the percentage of survival. The data shows the number of patients observed under censorship and the one that has been assigned the treatment. The data also provides the hazard ratio of 0.45 and p-value of 0.0187.*
Imatinib Mesylate Tablets by Aurobindo Pharma USA, Inc. is a prescription medicine containing 90 film-coated tablets. Each tablet contains Imatinib mesylate equivalent to 100mg of imatinib free base. It is used as per the instructions given in the package insert. It should be stored between 20°C to 25°C and protect it from moisture. It should be dispensed in a light container, USP. The package is distributed by Aurobindo Pharma USA, Inc. and made in India.*
This is a package of Imatinib Mesylate Tablets, with each tablet containing 400 mg of the active ingredient. The package contains 30 unit-dose tablets and should be stored at room temperature between 20-25°C. The tablets are distributed by Aurobindo Pharma USA, Inc. in East Windsor, NJ and are made in India. The package is only available with a prescription, and it is important to keep it out of the reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.